Therapeutic Outcome and Prognostic Factors of Invasive Aspergillosis in an Infectious Disease Department: A Review of 34 Cases

[1]  M. Boeckh,et al.  Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Lipton,et al.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.

[3]  E. Leray,et al.  Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  吉田 耕一郎,et al.  Multicenter clinical evaluation of the (1→3)β-D-glucan assay as an aid to diagnosis of fungal infections in humans: Ostrosky-Zeichner L, Alexander BD, Kett DH, et al: Clin Infect Dis 41 (5) : 654-659, 2005 , 2006 .

[5]  M. Naçar,et al.  Prevalence of brucellosis in the rural area of Kayseri, Central Anatolia, Turkey. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  G. Verhoef,et al.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  E. Thiel,et al.  Improved outcome in central nervous system aspergillosis, using voriconazole treatment. , 2005, Blood.

[8]  R. Piarroux,et al.  Use of Real-Time PCR To Process the First Galactomannan-Positive Serum Sample in Diagnosing Invasive Aspergillosis , 2005, Journal of Clinical Microbiology.

[9]  B. Alexander,et al.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Z. Memish,et al.  Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms. , 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  Nina Singh,et al.  Aspergillus Infections in Transplant Recipients , 2005, Clinical Microbiology Reviews.

[12]  Z. Memish,et al.  Importance of screening household members of acute brucellosis cases in endemic areas , 2004, Epidemiology and Infection.

[13]  M. Maris,et al.  Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. , 2003, Blood.

[14]  A. Mert,et al.  The sensitivity and specificity of Brucella agglutination tests. , 2003, Diagnostic microbiology and infectious disease.

[15]  K. Nas,et al.  Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. , 2003, Yonsei medical journal.

[16]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[17]  A. Mert,et al.  The diagnosis of brucellosis by use of BACTEC 9240 blood culture system. , 2002, Diagnostic microbiology and infectious disease.

[18]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[19]  C. Maslo,et al.  Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. , 2002, The Journal of hospital infection.

[20]  T. Carpenter,et al.  Time-Space Clustering of Human Brucellosis, California, 1973–1992 , 2002, Emerging infectious diseases.

[21]  R. Avery,et al.  Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[22]  J. Verhaegen,et al.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. , 2001, Blood.

[23]  S J Lin,et al.  Aspergillosis case-fatality rate: systematic review of the literature. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  F. Derouin,et al.  Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4‐year prospective study , 2001, Cancer.

[25]  P. Sullivan,et al.  Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  William R. Kirkpatrick,et al.  Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.

[27]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.

[28]  J. Latgé,et al.  Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  R Sylvester,et al.  An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. , 1998, The Journal of infection.

[30]  Z. Memish,et al.  Rapid diagnosis of Brucella bacteremia by using the BACTEC 9240 system , 1997, Journal of clinical microbiology.

[31]  P. Yagupsky,et al.  Rapid detection ofBrucella melitensis from blood cultures by a commercial system , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[32]  D. Denning.  Therapeutic outcome in invasive aspergillosis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  A. Groll,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 1996, The Journal of infection.

[34]  B. Mantur,et al.  Brucella melitensis—a sexually transmissible agent? , 1996, The Lancet.

[35]  R. Dagan,et al.  Detection and treatment of brucellosis by screening a population at risk , 1991, The Pediatric infectious disease journal.

[36]  D. Denning,et al.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.

[37]  E. Gotuzzo,et al.  [Epidemiological and clinical features of brucellosis in 39 family groups]. , 1989, Enfermedades infecciosas y microbiologia clinica.

[38]  R. Wise.  Brucellosis in the United States. Past, present, and future. , 1980, JAMA.

[39]  B. Thiers.  Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia , 2008 .

[40]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  T. Carpenter,et al.  Time-Space Clustering of Human Brucellosis, , 2002 .